Analysis of:
Multi MERCI(R) Trial Demonstrates Better Outcomes For Patients Suffering Ischemic Stroke (www.medicalnewstoday.com)
The article reports on the results of recent research showing the effectiveness of the Merci(R) Retrieval System. This pivotal study has contributed to the device receiving FDA approval
Analysis of:
Shire Receives Approvable Letter from FDA for INTUNIV(TM) (guanfacine) Extended Release, a Nonstimulant for the Treatment of ADHD (www.pipelinereview.com)
This is a helpful agent in ADHD for hyperactive symptoms. A long-acting form is critical in ADHD so no doses need to interrupt the school day. More even blood levels also an advantage.
Analysis of:
UPDATE: Novartis Wins FDA OK For Alzheimer's Drug Patch (money.cnn.com)
Alzheimer's drug patch could change quality of life of the patient and their family. Usually patients with Alzheimer's disease have more than one disease and takes three up to fifteen different medications a day. Long span release patches are very convenient to this patients for many reasons, not only...
Analysis of:
Rimonabant Regulatory Update in the United States (www.pipelinereview.com)
The company withdrew the application for rimonabant because the medication is unlikely to receive approval at this time with the regulatory documents available to FDA at this time. I believe that the FDA at this time would be adverse to approving a "lifestyle" medication for obesity especially using...
Analysis of:
Shire Receives Approvable Letter From FDA for INTUNIV(TM) (guanfacine) Extended Release, a Nonstimulant for the Treatment of ADHD (www.therapeuticsdaily.com)
My clinical experience with Tenex (guanfacine) was that it was most effective as an add-on treatment for ADHD with associated aggressive behavior. I expect that Intuniv will have the same efficacy limitations. Nonetheless, Intuniv's ease of use and tolerability along with FDA approval should...
Analysis of:
Aspect Medical Systems' psych treatment (biotech.seekingalpha.com)
I agree with Dr Martin, but it should also be noted that the "science" of using EEG to assess response to meds for psychiatric diseases (as opposed to epilepsy) typically uses quantitative and averaging methods, rather than raw data. The nature of EEG is dynamic and brief segmental...
Analysis of:
Over-The-Counter Weight Loss Drug Approved (abclocal.go.com)
Alli faces many difficulties in the marketplace which will limit sales in the long run and which may lead to litigation and FDA withdrawal.
Analysis of:
Pfizer To Launch Antiretroviral Maraviroc In July After FDA Tests Conclude, Official Says (www.medicalnewstoday.com)
Maraviroc will aid decrease HIV drug resistence. Because maraviroc's mechanism of action is different from the other antiretrovirals, its use can help those patients with HIV resistant mutations.
Analysis of:
U.S. urges strongest warning on 2 diabetes drugs (www.iht.com)
The recent meta-analysis published in the New England Journal of Medicine suggests an increased risk of myocardial infarction in patients taking rosiglitazone (Avandia). Additionally, there was an increased risk of death, but it did not reach stastistical significance. Black-box warnings are...
Analysis of:
New Treatment Offers Relief from Chronic Back Pain - Study Suggests Safe Treatment for a Variety of Conditions (www.medicalnewstoday.com)
(1) Chronic back pain is a challenge to treat with limited options. (2) The emergence of new therapies to help support efforts at physiotherapy are certainly hopeful signs for those with refractory pain. (3) There are concerns about this specific treatment, PRF.